SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-19-005041
Filing Date
2019-05-15
Accepted
2019-05-15 07:45:26
Documents
6
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A f10-ka.htm 10-K/A 119767
2 EX-10.11.1 ex-10d11d1.htm EX-10.11.1 156181
3 EX-10.12.1 ex-10d12d1.htm EX-10.12.1 30585
4 EX-31.3 ex-31d3.htm EX-31.3 7974
5 EX-31.4 ex-31d4.htm EX-31.4 7589
6 GRAPHIC ex-10d11d1g001.jpg GRAPHIC 4064
  Complete submission text file 0001558370-19-005041.txt   328857
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38586 | Film No.: 19825101
SIC: 2836 Biological Products, (No Diagnostic Substances)